KINETA CHRONIC PAIN LLC has a total of 12 patent applications. Its first patent ever was published in 2015. It filed its patents most often in United States, Taiwan and Australia. Its main competitors in its focus markets pharmaceuticals and biotechnology are IDP DISCOVERY PHARMA S L, RADIMMUNE THERAPEUTICS INC and DENNIS MARK S.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 3 | |
#2 | Taiwan | 2 | |
#3 | Australia | 1 | |
#4 | Canada | 1 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | Hong Kong | 1 | |
#7 | Japan | 1 | |
#8 | Republic of Korea | 1 | |
#9 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Munoz Ernesto J | 6 |
#2 | Iadonato Shawn P | 5 |
#3 | Iadonato Shawn | 4 |
#4 | Mercado Jose | 3 |
#5 | Posakony Jeffrey J | 2 |
#6 | Posakony Jeffrey Jerard | 2 |
#7 | Tarcha Eric J | 2 |
#8 | Posakony Jeffrey | 1 |
#9 | Shawn P Iadonato | 1 |
#10 | Ernesto J Munoz | 1 |
Publication | Filing date | Title |
---|---|---|
US2020237924A1 | Conotoxin peptide analogs and uses for the treatment of pain and inflammatory conditions | |
TW202026305A | Conotoxin peptide analogs and uses for the treatment of pain and inflammatory conditions | |
WO2020142102A1 | Conotoxin peptide analogs and uses for the treatment of pain and inflammatory conditions | |
AU2015342767A1 | Modifications and uses of conotoxin peptides |